Zeer Quotient Sciences / intent / quotient-sciences

Quotient Sciences

1001-5000 employees·Nottingham, United Kingdom·quotientsciences.com

Observed, not inferred · updated weekly

Buying intent

39 tracked signals | Top 15 topics are below | Sales and Product are carrying most of it.

33signals · 30 days
21topics tracked
34.78%attributed to a team

Attention by team

LinkedIn activity, by team

Where Quotient Sciences's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Artificial Intelligence
Drug Development
Clinical Trials
Talent Management
Digital Twin
Drug Delivery Systems
Sales
Medium40% of team Sales to Artificial Intelligence: Medium, 40% of this team's signals
Medium40% of team Sales to Drug Development: Medium, 40% of this team's signals
Low20% of team Sales to Clinical Trials: Low, 20% of this team's signals
Sales to Talent Management: no signal
Sales to Digital Twin: no signal
Sales to Drug Delivery Systems: no signal
Product
High100% of team Product to Artificial Intelligence: High, 100% of this team's signals
Product to Drug Development: no signal
Product to Clinical Trials: no signal
Product to Talent Management: no signal
Product to Digital Twin: no signal
Product to Drug Delivery Systems: no signal
Others
Medium13% of team Others to Artificial Intelligence: Medium, 13% of this team's signals
High27% of team Others to Drug Development: High, 27% of this team's signals
Medium13% of team Others to Clinical Trials: Medium, 13% of this team's signals
High20% of team Others to Talent Management: High, 20% of this team's signals
Medium13% of team Others to Digital Twin: Medium, 13% of this team's signals
Medium13% of team Others to Drug Delivery Systems: Medium, 13% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Artificial Intelligence
LinkedIn
High volume
96%
last
12d ago
Drug Development
LinkedIn
High volume
98%
last
16d ago
Clinical Trials
LinkedIn
Medium volume
97%
last
17d ago
Talent Management
LinkedIn
Medium volume
98%
last
17d ago
Digital Twin
LinkedIn
Low volume
97%
last
17d ago
Drug Delivery Systems
LinkedIn
Low volume
98%
last
20d ago
Operational Excellence
LinkedIn
Low volume
96%
last
12d ago
Generative AI
LinkedIn
Low volume
98%
last
12d ago
Supply Chain
LinkedIn
Low volume
92%
last
10d ago
Career Development
LinkedIn
Low volume
94%
last
17d ago
Drug Discovery
LinkedIn
Low volume
96%
last
21d ago
Pharmaceutical
LinkedIn
Low volume
94%
last
16d ago
Email Campaign
LinkedIn
Low volume
98%
last
12d ago
Enterprise Data Management
LinkedIn
Low volume
98%
last
21d ago
Data Integrity
LinkedIn
Low volume
98%
last
12d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at Quotient Sciences

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others7 active
researching Drug Development
in
researching Drug Delivery Systems
in
Executiveresearching Digital Twin
in
Leadershipresearching Career Development
in
Leadershipresearching Supply Chain
in
researching Clinical Trials
in
Sales2 active
researching Drug Development
in
Directorresearching Artificial Intelligence
in
Product1 active
Directorresearching Artificial Intelligence
in

Primary products / business lines

LinkedIn company profile

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions,

Top accounts researching Quotient Sciences

names withheld on the public page

These are companies whose own people brought up Quotient Sciences unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

151,426 companies · 839,012 people are researching Artificial Intelligence

Quotient Sciences's own team shows 7 signals on this topic. No one outside Quotient Sciences has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Drug Development1,331 cos · 4,701 people
  • Clinical Trials4,086 cos · 17,225 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching Quotient Sciences.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Sales — 2 people; Leadership — 1 person; Product — 1 person

What's been said

public posts by Quotient Sciences's team

No public post naming Quotient Sciences has surfaced in the past year, so this is what Quotient Sciences's own team is posting about publicly — their topics, in their words.

LinkedIn

Attending #CPHIAmericas ? Let's connect to discuss your program needs and explore how #QuotientSciences can support you through our #TranslationalPharmaceutics ® platform. This disruptive approach to drug development seamlessly integrates formulation development, #drugproduct manufacturing, and #clinical testing. Schedule a time to meet at the event today: https://bit.ly/4u9JhMk

May 2026

About this data. Quotient Sciences (quotientsciences.com). Department attribution is 34.78%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries